<DOC>
	<DOCNO>NCT00673504</DOCNO>
	<brief_summary>Primary objective : evaluate whether addition sunitinib prolongates Progression-Free Survival ( PFS ) patient advanced pancreatic cancer receive first-line gemcitabine chemotherapy .</brief_summary>
	<brief_title>First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced Metastatic Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Patients suffer locally advanced metastatic pancreatic cancer Patients measurable disease ( least one unidimensionally measurable target lesion CTscan MRI ) accord Response Evaluation Criteria Solid Tumors ( RECIST ) . ECOG performance status 0 1 Signed write informed consent . White blood cell count ( WBC ) &gt; = 3x10^9/L neutrophil &gt; = 1.5 x 10^9/L , platelet count &gt; = 100x10^9/L , hemoglobin &gt; = 5.6 mmol/L ( 9 g/dL ) . Total bilirubin &lt; 2 x upper limit normal . AST ALT &lt; 2.5 x upper limit normal , &lt; 5 x upper limit normal case liver metastasis . Serum creatinine &lt; 1.5 x upper limit normal Normal ECG without QT prolongation Resectable pancreatic cancer Previous chemotherapy ( adjuvant metastatic disease ) Any investigational drug within 30 day inclusion . Prior use sunitinib multitarget tyrosine kinase inhibitor Pregnancy ( absence confirm betahCG test ) lactation period . Men woman childbearing potential sexually active unwilling use medically acceptable method contraception trial . Clinically symptomatic brain meningeal metastasis . ( know suspect ) Cardiac arrhythmia require antiarrhythmic ( exclude beta blocker digoxin ) . History follow cardiac event within past 6 month : myocardial infarction ( include severe/unstable angina ; coronary/peripheral artery bypass graft ; symptomatic congestive heart failure ( CHF ) &gt; NYHA Class II ; cerebrovascular accident transient ischemic attack ; pulmonary embolism Uncontrolled severe hypertension ( failure diastolic blood pressure fall 90 mm Hg despite use 3 antihypertensive drug Acute subacute intestinal occlusion history inflammatory bowel disease chronic diarrhea Previous malignancy ( pancreatic cancer ) last 5 year except basal cell cancer skin , preinvasive cancer cervix superficial bladder tumor [ Ta , Tis T1 ] . History organ allograft Patients require longterm cortisone therapy Patients require oral anticoagulation treatment ( marcoumar )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>cancer</keyword>
	<keyword>pancreatic cancer</keyword>
	<keyword>gemcitabine</keyword>
	<keyword>sunitinib</keyword>
	<keyword>Phase 2</keyword>
</DOC>